LISATA THERAPEUTICS, INC. Payments to Acquire Other Investments
LISATA THERAPEUTICS, INC. (LSTA) reported Payments to Acquire Other Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. payments to acquire other investments for the quarter ending 2024-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for the quarter ending 2024-09-30 was $30.00K.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for the quarter ending 2024-06-30 was $0.00.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for the quarter ending 2024-03-31 was $100.00K.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for fiscal 2024 was $130.00K.
- LISATA THERAPEUTICS, INC. payments to acquire other investments for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Other Investments | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $30.00K derived: sum of 2 quarters · filed 2026-03-12 | $30.00K derived: sum of 3 quarters · filed 2026-03-12 | $130.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $30.00K derived: sum of 2 quarters · filed 2024-11-12 | $130.00K 10-Q · filed 2024-11-12 | $130.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $100.00K 10-Q · filed 2024-08-12 | $100.00K derived: sum of 3 quarters · filed 2025-02-27 | $100.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-09 | $100.00K derived: sum of 2 quarters · filed 2025-02-27 | $100.00K derived: sum of 3 quarters · filed 2025-02-27 | $100.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2024-03-15 | $100.00K 10-Q · filed 2024-08-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |